Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0041 | 0.0214 | 0.5 | |
Leishmania major | target of rapamycin (TOR) kinase 1, putative | 0.0071 | 0.052 | 0.1447 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0071 | 0.052 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.004 | 0.0211 | 0.3882 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0655 | 0.6342 | 0.6342 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.012 | 0.0238 |
Echinococcus multilocularis | tyrosine protein kinase ABL1 | 0.0135 | 0.1152 | 0.1152 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0071 | 0.052 | 1 |
Brugia malayi | hypothetical protein | 0.0027 | 0.0083 | 0.0383 |
Schistosoma mansoni | fkbp-rapamycin associated protein | 0.004 | 0.0211 | 0.0844 |
Echinococcus granulosus | serine protein kinase ATM | 0.004 | 0.0211 | 0.0211 |
Echinococcus multilocularis | serine protein kinase ATM | 0.004 | 0.0211 | 0.0211 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.004 | 0.0211 | 0.3882 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0045 | 0.0256 | 0.4786 |
Toxoplasma gondii | FATC domain-containing protein | 0.004 | 0.0211 | 0.3247 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0026 | 0.0074 | 0.0178 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0071 | 0.052 | 0.2085 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0042 | 0.0233 | 0.3739 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0045 | 0.0256 | 0.4786 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.0233 | 0.0704 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0071 | 0.052 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.004 | 0.0209 | 0.0606 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0269 | 0.2495 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.004 | 0.0211 | 0.265 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0071 | 0.052 | 0.2085 |
Echinococcus multilocularis | snurportin 1 | 0.0269 | 0.2495 | 0.2495 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0071 | 0.052 | 0.052 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0042 | 0.0233 | 0.3739 |
Loa Loa (eye worm) | nucleolar RNA-associated protein alpha | 0.0269 | 0.2495 | 1 |
Echinococcus granulosus | tyrosine protein kinase ABL1 | 0.0135 | 0.1152 | 0.1152 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0211 | 0.3882 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.004 | 0.0211 | 0.3882 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0071 | 0.052 | 0.052 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0042 | 0.0233 | 1 |
Brugia malayi | hypothetical protein | 0.0042 | 0.0233 | 0.3051 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0071 | 0.052 | 0.1883 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0133 | 0.1132 | 0.4538 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0026 | 0.0074 | 0.1183 |
Echinococcus granulosus | PIK kinase FAT and Armadillo domain containing protein | 0.0031 | 0.012 | 0.012 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0071 | 0.052 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0042 | 0.0233 | 0.0652 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Echinococcus multilocularis | serine:threonine protein kinase SMG1 | 0.004 | 0.0211 | 0.0211 |
Brugia malayi | Tyrosine-protein kinase abl-1 | 0.0055 | 0.0357 | 0.5257 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.004 | 0.0209 | 0.2626 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.004 | 0.0209 | 0.0839 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Loa Loa (eye worm) | TK/ABL protein kinase | 0.0135 | 0.1152 | 0.4478 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0071 | 0.052 | 0.1883 |
Echinococcus multilocularis | DNA dependent protein kinase catalytic subunit | 0.1023 | 1 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0071 | 0.052 | 0.8161 |
Entamoeba histolytica | Phosphatidylinositol 3- and 4-kinase family | 0.004 | 0.0211 | 0.3882 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.004 | 0.0211 | 0.3882 |
Toxoplasma gondii | non-specific serine/threonine protein kinase | 0.0045 | 0.0256 | 0.4245 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.004 | 0.0211 | 0.3882 |
Brugia malayi | RNA, U transporter 1 | 0.0072 | 0.0526 | 0.8256 |
Echinococcus multilocularis | PIK kinase, FAT and Armadillo domain containing protein | 0.0031 | 0.012 | 0.012 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0071 | 0.052 | 0.1506 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0071 | 0.052 | 0.1506 |
Leishmania major | target of rapamycin (TOR) kinase 2, putative | 0.0071 | 0.052 | 0.1447 |
Giardia lamblia | GTOR | 0.0071 | 0.052 | 0.5 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0071 | 0.052 | 0.1506 |
Loa Loa (eye worm) | hypothetical protein | 0.0045 | 0.0256 | 0.08 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0071 | 0.052 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0358 | 0.3374 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.0319 | 0.1057 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0041 | 0.0214 | 0.0858 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0071 | 0.052 | 0.1506 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.004 | 0.0211 | 0.3882 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.004 | 0.0211 | 0.265 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0042 | 0.0233 | 0.0652 |
Echinococcus granulosus | serine:threonine protein kinase SMG1 | 0.004 | 0.0211 | 0.0211 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0042 | 0.0233 | 0.0626 |
Echinococcus granulosus | importin subunit beta 1 | 0.0025 | 0.0062 | 0.0062 |
Brugia malayi | Tyrosine-protein kinase abl-1 | 0.0082 | 0.0624 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.004 | 0.0209 | 0.0209 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0042 | 0.0233 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.004 | 0.0209 | 0.0209 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0071 | 0.052 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.004 | 0.0209 | 0.0839 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.004 | 0.0211 | 0.3882 |
Brugia malayi | FAT domain containing protein | 0.0031 | 0.012 | 0.1033 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.004 | 0.0209 | 0.0209 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0214 | 0.0625 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0071 | 0.052 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0211 | 0.0612 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0026 | 0.0074 | 0.1183 |
Echinococcus granulosus | tumor protein p63 | 0.0277 | 0.2568 | 0.2568 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0074 | 0.005 |
Leishmania major | target of rapamycin kinase (TOR) kinase 3 | 0.0071 | 0.052 | 0.1447 |
Trypanosoma brucei | phosphatidylinositol kinase related protein, putative | 0.004 | 0.0211 | 0.3247 |
Entamoeba histolytica | protein kinase rad3, putative | 0.004 | 0.0211 | 0.3882 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Schistosoma mansoni | importin beta-1 | 0.0025 | 0.0062 | 0.0248 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm) | 0.004 | 0.0211 | 0.0844 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0071 | 0.052 | 0.052 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.004 | 0.0209 | 0.0839 |
Echinococcus multilocularis | tumor protein p63 | 0.0277 | 0.2568 | 0.2568 |
Echinococcus multilocularis | importin subunit beta 1 | 0.0025 | 0.0062 | 0.0062 |
Echinococcus multilocularis | tyrosine protein kinase Abl | 0.0055 | 0.0357 | 0.0357 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0042 | 0.0233 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0031 | 0.012 | 0.2087 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Leishmania major | phosphatidylinositol 3-related kinase, putative | 0.0071 | 0.052 | 0.1447 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0045 | 0.0256 | 0.4245 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0071 | 0.052 | 0.8161 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Leishmania major | phosphatidylinositol 3-kinase, putative | 0.0071 | 0.052 | 0.1447 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.004 | 0.0211 | 0.3882 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0071 | 0.052 | 0.052 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.004 | 0.0211 | 0.0585 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0071 | 0.052 | 1 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase, putative | 0.004 | 0.0211 | 0.0585 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0071 | 0.052 | 1 |
Echinococcus granulosus | snurportin 1 | 0.0269 | 0.2495 | 0.2495 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0071 | 0.052 | 0.1506 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.004 | 0.0209 | 0.0209 |
Leishmania major | hypothetical protein, conserved | 0.0371 | 0.3511 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0031 | 0.012 | 0.048 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4.917 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.915 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.73 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.709 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.685 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.673 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.64 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.561 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.478 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.